Equities analysts forecast that Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) will report earnings of $0.18 per share for the current fiscal quarter, Zacks reports. Ten analysts have issued estimates for Allscripts Healthcare Solutions’ earnings, with the lowest EPS estimate coming in at $0.17 and the highest estimate coming in at $0.20. Allscripts Healthcare Solutions posted earnings per share of $0.14 during the same quarter last year, which would suggest a positive year-over-year growth rate of 28.6%. The company is expected to issue its next earnings results after the market closes on Thursday, February 15th.

On average, analysts expect that Allscripts Healthcare Solutions will report full year earnings of $0.62 per share for the current fiscal year, with EPS estimates ranging from $0.60 to $0.64. For the next year, analysts anticipate that the business will report earnings of $0.76 per share, with EPS estimates ranging from $0.72 to $0.89. Zacks’ EPS averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings data on Thursday, November 2nd. The software maker reported $0.12 EPS for the quarter, meeting analysts’ consensus estimates of $0.12. Allscripts Healthcare Solutions had a positive return on equity of 6.53% and a negative net margin of 12.23%.

MDRX has been the topic of a number of recent analyst reports. KeyCorp reiterated a “hold” rating on shares of Allscripts Healthcare Solutions in a report on Friday, October 27th. Zacks Investment Research downgraded Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a report on Wednesday, November 8th. Robert W. Baird increased their price objective on Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the company an “outperform” rating in a report on Friday, November 3rd. Maxim Group reiterated a “buy” rating and issued a $20.00 price objective on shares of Allscripts Healthcare Solutions in a report on Tuesday, January 9th. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $17.00 price objective on shares of Allscripts Healthcare Solutions in a report on Monday, January 8th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and eleven have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $15.66.

In related news, SVP James Hewitt sold 36,796 shares of the company’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $14.11, for a total value of $519,191.56. Following the completion of the sale, the senior vice president now directly owns 181,766 shares of the company’s stock, valued at approximately $2,564,718.26. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, President Richard J. Poulton sold 15,000 shares of the company’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $14.26, for a total value of $213,900.00. Following the completion of the sale, the president now directly owns 1,351,773 shares of the company’s stock, valued at $19,276,282.98. The disclosure for this sale can be found here. Over the last three months, insiders sold 56,796 shares of company stock valued at $804,842. Insiders own 0.91% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its position in Allscripts Healthcare Solutions by 0.4% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 26,484 shares of the software maker’s stock worth $338,000 after acquiring an additional 115 shares during the period. ETRADE Capital Management LLC lifted its position in Allscripts Healthcare Solutions by 4.6% during the 2nd quarter. ETRADE Capital Management LLC now owns 38,612 shares of the software maker’s stock worth $493,000 after acquiring an additional 1,710 shares during the period. BlueCrest Capital Management Ltd lifted its position in Allscripts Healthcare Solutions by 26.0% during the 2nd quarter. BlueCrest Capital Management Ltd now owns 20,652 shares of the software maker’s stock worth $264,000 after acquiring an additional 4,265 shares during the period. Sterling Capital Management LLC lifted its position in Allscripts Healthcare Solutions by 5.4% during the 2nd quarter. Sterling Capital Management LLC now owns 94,511 shares of the software maker’s stock worth $1,206,000 after acquiring an additional 4,875 shares during the period. Finally, Archford Capital Strategies LLC lifted its position in Allscripts Healthcare Solutions by 6,124.0% during the 2nd quarter. Archford Capital Strategies LLC now owns 6,224 shares of the software maker’s stock worth $958,000 after acquiring an additional 6,124 shares during the period.

Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at $15.24 on Monday. Allscripts Healthcare Solutions has a 1-year low of $11.01 and a 1-year high of $16.13. The company has a market capitalization of $2,750.00, a PE ratio of -13.14, a PEG ratio of 2.15 and a beta of 1.32. The company has a debt-to-equity ratio of 1.20, a current ratio of 0.98 and a quick ratio of 0.98.

ILLEGAL ACTIVITY WARNING: This piece of content was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of US & international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2018/01/22/allscripts-healthcare-solutions-inc-mdrx-expected-to-announce-earnings-of-0-18-per-share.html.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Get a free copy of the Zacks research report on Allscripts Healthcare Solutions (MDRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.